Floatz logo

RETEPLASE, RECOMBINANT

Thrombectomy

Changhai Hospitalprotein_peptideN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

11 Active assets in the Thrombectomy cohort.

Asset / SponsorPhaseRating
Recombinant Human Plasminogen Activator
Xuanwu Hospital, Beijing
Phase 4B
CISATRACURIUM ION
University Hospital, Clermont-Ferrand
N/AD
Tenecteplase
Xuanwu Hospital, Beijing
N/AD
Tirofiban
Xuanwu Hospital, Beijing
N/AD
Plavix
Xueli Cai
N/AD

View all 12 →

Same molecule, other indications

RETEPLASE, RECOMBINANT is also rated in:

Acute Ischemic StrokeDormant
B
Indicative ·
63 / 100
View asset →
Basilar Artery OcclusionDormant
B
Indicative ·
60 / 100
View asset →
stroke disorderDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →